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OBJECTIVE: Large vessel occlusion in acute ischemic stroke is associated with low recanalization rates under
intravenous thrombolysis. We evaluated the safety and efficacy of the Solitaire AB stent in treating acute ischemic
stroke.
METHODS: Patients presenting with acute ischemic stroke were prospectively evaluated. The neurological outcomes
were assessed using the National Institutes of Health Stroke Scale and the modified Rankin Scale. Time was recorded
from the symptom onset to the recanalization and procedure time. Recanalization was assessed using the
thrombolysis in cerebral infarction score.
RESULTS: Twenty-one patients were evaluated. The mean patient age was 65, and the National Institutes of Health
Stroke Scale scores ranged from 7 to 28 (average 17¡6.36) at presentation. The vessel occlusions occurred in the
middle cerebral artery (61.9%), distal internal carotid artery (14.3%), tandem carotid occlusion (14.3%), and basilar
artery (9.5%). Primary thrombectomy, rescue treatment and a bridging approach represented 66.6%, 28.6%, and
4.8% of the performed procedures, respectively. The mean time from symptom onset to recanalization was
356.5¡107.8 minutes (range, 80-586 minutes). The mean procedure time was 60.4¡58.8 minutes (range, 14-240
minutes). The overall recanalization rate (thrombolysis in cerebral infarction scores of 3 or 2b) was 90.4%, and the
symptomatic intracranial hemorrhage rate was 14.2%. The National Institutes of Health Stroke Scale scores at
discharge ranged from 0 to 25 (average 6.9¡7). At three months, 61.9% of the patients had a modified Rankin Scale
score of 0 to 2, with an overall mortality rate of 9.5%.
CONCLUSIONS: Intra-arterial thrombectomy with the Solitaire AB device appears to be safe and effective. Large
randomized trials are necessary to confirm the benefits of this approach in acute ischemic stroke.
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INTRODUCTION
Ischemic stroke is the third leading cause of death and the
leading cause of long-term disability worldwide (1); it is
the leading cause of mortality in Brazil (2). An increased
national incidence of stroke is expected, and preventive and
acute medical care is needed (3). Despite the rising
occurrence of strokes and stroke-related deaths, the adult
Brazilian population has demonstrated an alarming lack
of knowledge about stroke prevention, recognition, and
treatment (4). Although national initiatives aimed at
improving stroke care have been implemented (5), few
national studies have examined intra-arterial recanalization
therapies for acute ischemic stroke.
Intravenous thrombolysis using a recombinant tissue
plasminogen activator (TPA) for arterial recanalization is
the standard treatment for acute ischemic stroke (6,7).
Recanalization is strongly associated with clinical outcomes
(8). Intravenous thrombolysis has not been associated with
high recanalization rates in large vessel occlusions (9,10). In
this setting, intra-arterial thrombectomy with retrievable
stent devices has reportedly achieved higher recanalization
rates and shorter recanalization times (11-28). The aim of
this study was to assess the safety and efficacy of the
Solitaire AB device (ev3, Irvine, CA, USA) in acute ischemic
stroke patients who were prospectively evaluated and
treated at the Clinics Hospital of the Ribeira˜o Preto
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Medical School, Sa˜o Paulo, Brazil. The literature on intra-
arterial recanalization therapies was reviewed and com-
pared to the results of the present study.
METHODS
Patient Population
We prospectively followed a group of patients who were
treated for acute ischemic stroke with the Solitaire AB
device (ev3, Irvine, CA, USA) by the same stroke team from
June 2011 to January 2012. The study was approved by the
ethics committee at our institution. The patients or their
legal representatives signed the consent forms that were
previously approved by the institutional review board. The
patients were selected for intra-arterial recanalization
treatment according to our institution’s acute stroke proto-
col for recanalization strategies. Initially, the patients were
assessed for eligibility for intravenous thrombolysis using
the National Institutes of Neurological Disorders and the
European Cooperative Stroke Study 3 trial criteria (1,2). The
endovascular recanalization procedures have three modal-
ities: rescue treatment, a bridging approach, and primary
thrombectomy. All of the patients who were eligible for
standard intravenous thrombolysis were considered for
rescue intra-arterial therapy if they exhibited a persistent
proximal occlusion at the end of intravenous fibrinolysis.
Likewise, the patients were considered for bridging intra-
arterial therapy if they presented with a tandem carotid
occlusion or basilar occlusion, which are known to have low
recanalization rates with intravenous TPA (9,10). The
patients who were ineligible for intravenous fibrinolysis
were treated with primary thrombectomy. Patients were
excluded from intra-arterial therapy if they presented with
hypoattenuation in more than one-third of the middle
cerebral artery territory on brain computed tomography
(CT) or if intra-arterial recanalization could not be
performed within eight hours of symptom onset for anterior
circulation stroke or within nine hours for posterior
circulation stroke.
The arterial occlusion site was assessed with either
combined transcranial color-coded duplex (TCCD) and
carotid ultrasound (US) or brain computed tomography
angiography (CTA). When vessel imaging was unavailable,
a score$10 on the National Institutes of Health Stroke Scale
(NIHSS), coma, tetraparesis and locked-in syndrome were
used as the proximal occlusion criteria.
Patient assessment and follow-up
The stroke severity was assessed using the NIHSS upon
admission. A brain CT scan was quickly performed to
determine the brain tissue injury pattern. When available,
TCCD and carotid US were also performed in the acute
phase to assess the artery occlusion site. If visualizing the
intracranial arteries was not possible using TCCD, a CTA
scan was performed. A second and third brain CT scan were
obtained immediately after thrombolysis and between 24
and 48 hours after treatment, respectively. All of the patients
were kept under observation until discharge and were
followed up three months after their strokes. The patient
outcomes were assessed by certified examiners at discharge
(NIHSS) and the three-month follow-up (modified Rankin
Scale, mRS). The time from the symptom onset to the
recanalization and procedure times were recorded. The
procedure time began with the groin puncture and ended at
the instant of recanalization. Recanalization was assessed
using the thrombolysis in cerebral infarction score (TICI)
(29). The number of Solitaire AB device (ev3, Irvine, CA,
USA) passes was recorded.
Rescue treatment
Standard intravenous thrombolysis was performed with a
0.9 mg/kg dose of TPA (with a maximum total dose of
90 mg), which was delivered as an initial bolus of 10% with
the remaining 90% infused within 60 minutes. The patients
Figure 1 - (a) Digital subtraction angiography (DSA) of the right common carotid artery ([RCCA] arterial phase, oblique view) shows an
occlusion of the distal right internal carotid artery (RICA) (black arrow); (b) a road map of the RICA (oblique view) shows a guiding
catheter in the RICA (arrowhead); the distal tip of the microcatheter (white arrow) and the microwire have crossed the occluded
portion of the RICA and moved through the thrombi and into the right middle cerebral artery (RMCA) (black arrow); (c) a road map of
the RICA (oblique view) shows the terminal tip of microcatheter (white arrow) distal to the occlusion site; (d) a road map of the RICA
(oblique view) shows the terminal tip of the microcatheter (white arrow) and the terminal radiopaque marks of a 6x30 mm Solitaire AB
device (ev3, Irvine, CA, USA), which indicate the start of deployment (white arrowhead); (e) a road map of the RICA (oblique view) in
which the proximal stent radiopaque mark is seen ahead of the distal tip of microcatheter (white arrowhead), indicating the full
deployment of the stent into the RMCA and the distal RICA; (f) a control DSA of the RCCA (arterial phase, oblique view) that was
performed after the stent retrieval shows that the distal RICA, right anterior cerebral artery (RACA) and RMCA branches have been
completely opened; (g) a picture shows the Solitaire AB (ev3, Irvine, CA, USA) and the removed clot.
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were monitored using NIHSS assessment and continuous
TCCD. An urgent rescue thrombectomy was performed 60
minutes after the bolus if a persistent proximal occlusion
was visible on TCCD or the NIHSS score did not improve
by$4 points (if TCCD was unavailable).
Bridging approach
The patients who presented with carotid tandem
occlusion or basilar artery occlusion associated with coma,
tetraparesis or locked-in syndrome within 4.5 hours of the
symptom onset were placed on intravenous fibrinolysis
using TPA at a dose of 0.6 mg/kg (15% as a bolus and
the remaining 85% as an infusion after 30 minutes), and
the angiography suite was prepared for an urgent
thrombectomy.
Primary thrombectomy
Primary thrombectomy was indicated for those patients
with acute ischemic stroke who were ineligible for intrave-
nous fibrinolysis and those patients presenting between 4.5
and 8 hours after the onset of an anterior circulation
occlusion or between 4.5 and 9 hours after the onset of a
posterior circulation occlusion.
Neurointerventional procedure
For the thrombectomy, the patient was transferred to the
angiography suite, where the intubation was performed.
The patient’s blood pressure was carefully monitored
throughout the anesthesia induction and the procedure to
maintain a minimum pressure of 180 mm Hg (systolic
arterial pressure) or 80 mm Hg (mean arterial pressure). If
there were no complications, the patient was extubated
immediately after the procedure.
All of the procedures were performed using the femoral
artery approach. An intravenous bolus of 5,000 IU of
standard heparin was administered after the puncture if
intravenous TPA was not previously infused. If TPA was
infused prior to the endovascular procedure, no heparin
was administered after the femoral puncture. A 7-Fr
guiding catheter (Guider Softip; Boston Scientific, Natick,
MA) or a 6-Fr guiding catheter (Neuron; Penumbra,
Alameda, CA) was introduced through a femoral sheath
into the internal carotid artery or the most navigable
vertebral artery (related to the ischemic vascular territory).
The guiding catheter was continuously perfused with a
solution of 40 mg of verapamil hydrochloride diluted in
1,000 mL of physiological saline (0.9%). Frontal, oblique,
Figure 2 - (a) DSA of the left common carotid artery (LCCA), arterial phase, frontal view, shows a proximal occlusion of M1 segment of
left middle cerebral artery (LMCA) (black arrow); (b) DSA of left interna carotid artery (LICA), arterial phase, frontal view, shows a
Solitaire AB (ev3, Irvine, CA, USA) deployed into the M1 segment and promptly flow restoration of LMCA (black arrow); (c) Final control
DSA of the LCCA, arterial phase, frontal view, shows the complete recanalization of the LMCA; (d, e, f) road maps of LICA, frontal views,
show (d) the microwire crossed the occluded LMCA (black arrow), (e) the terminal tip of the microcatheter (black arrow) placed beyond
the thrombi into the M1 segment of the LMCA and (f) terminal radiopaque marks of a 4x20 mm Solitaire AB device (ev3) deployed into
the occluded site of LMCA; (g, h, i) Brain CT scans, (g) performed on presentation revealing no signs of hemorrhage or ischemic injury,
(h) performed immediately after intra-arterial thrombectomy showing contrast medium enhance in the left middle cerebral artery
territory and (i) performed 48 hours after intra-arterial thrombectomy showing contrast medium cleared and slight parenchymal
hypoattenuation signs.
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and lateral angiography series were completed to determine
the cervical vessel that was related to the ischemic territory
of the brain and to define the occluded intracranial vessels.
If a proximal carotid or vertebral occlusion was identified, a
Wallstent or Express stent, respectively, (both by Boston
Scientific Target, Fremont, CA, USA) was used to perform
an angioplasty stenting procedure. After stenting, the
guiding catheter was placed into the cervical artery, and a
manual thrombus aspiration was performed. After this step,
or if no proximal cervical artery occlusion was identified, a
0.021-inch Rebar 18 or a 0.027-inch Rebar 27 microcatheter
(ev3, Irvine, CA, USA) was navigated distal to the point of
occlusion over a 0.014-inch steerable microwire (Transend
EX Platinum; Boston Scientific Target). The microwire was
exchanged with a 4620 mm or 6630 mm Solitaire AB
device (ev3, Irvine, CA, USA). The device was left in place
for 3 to 5 minutes. Then, the microcatheter was advanced to
recoat the first third of the Solitaire AB device (ev3, Irvine,
CA, USA). The fully deployed Solitaire AB device and the
delivery microcatheter were gently pulled back as a single
unit and recovered via manual aspiration of the guiding
catheter; this procedure was performed with a 60 mL
syringe. Successful recanalization was defined as a TICI
score of 3 or 2b in all of the treatable vessels. If the treatable
vessel was not opened to a minimum of TICI 2b after a
maximum of eight passes of the thrombectomy device, the
treatment was considered to be a failure. No intra-arterial
fibrinolytics were administered, even if the recanalization
attempt was unsuccessful. The groin punctures were closed
with an Angio-Seal (St. Jude Medical, St. Paul, MN).
Endpoints, statistical analysis and literature review
We collected clinical and radiological data from all of the
study subjects. The mean and standard deviation (SD) were
calculated for the numeric variables, and Fisher’s exact test
was used for the categorical data. All of the statistical
analyses were performed with SPSS version 20.0 (Chicago,
IL). We searched PubMed for studies published through
May 1, 2012 that evaluated retrieval devices for acute
ischemic stroke and large intra-arterial therapy for acute
ischemic stroke trials. The percentage of recanalization,
percentage of mRS scores#2 at 3 months, symptomatic
hemorrhage rates and mortality rates in the present study
were compared to those in the earlier large trials.
RESULTS
Twenty-one patients were evaluated. Vessel imaging
(TCCD and US or CTA) was performed on all of the
subjects. The mean patient age was 65 years, and the
patients’ NIHSS scores ranged from 7 to 28 (average 17,
SD¡6.36) on presentation. Vessel occlusions were located in
the middle cerebral artery (61.9%), distal internal carotid
artery (14.3%), tandem carotid occlusion (14.3%), and basilar
artery (9.5%). Primary thrombectomy, rescue treatment and
the bridging approach were performed in 66.6%, 28.6%, and
4.8% of the procedures, respectively. The mean time from
symptom onset to recanalization was 356.5¡107.8 (SD)
minutes (range, 80–586 minutes). The mean procedure times
were 60.4¡58.8 (SD) minutes (range, 14–240 minutes), and
45.7¡35.7 minutes for the successful procedures. We
obtained an overall recanalization rate (TICI scores of 2b
and 3) of 90.4% and a symptomatic intracranial hemorrhage
rate of 14.2%. The number of device passes ranged from 1 to
8 (average 3.1, SD¡2.4). There were no device fractures or
arterial dissections. The NIHSS scores at discharge ranged
from 0 to 25 (average 6.9, SD¡7.0). At three months, 61.9%
of the patients had an mRS score#2.
The overall mortality rate was 9.5%. One (4.7%) patient
died from pneumonia after being discharged. Symptomatic
hemorrhagic complications were observed in three patients
(14.2%), one of whom (4.7%) had a subarachnoid hemorrhage
and died during hospitalization. The other two patients
(9.4%) presented with hemorrhagic transformation and were
completely dependent on caregivers at the three-month
follow-up. Contrast medium enhancement was observed in
12 cases (57.1%). The patients’ clinical and technical data are
summarized in Table 1. Figures 1, 2 and 3 illustrate
procedures with patients 12, 14 and 20, respectively.
We reviewed the literature and compared our results with
the results from 17 studies that investigated retrieval
devices for treating acute stroke (11-27). We investigated
the recanalization rate, recanalization time, procedure time,
symptomatic intracranial hemorrhage rate, 90-day mortality
rate, average patient NIHSS upon presentation, and study
outcomes. Overall, the results were similar (Table 2).
Figure 3 - (a, b) a DSA of (a) the right vertebral artery (RVA) and (b)
the left vertebral artery (LVA) (white arrows), arterial phase,
frontal views, shows an occlusion of the proximal basilar artery
(BA) (white arrowheads); (c) a DSA of the LCCA (frontal view)
shows the BA (white arrow) filled by the left posterior commu-
nicating artery; (d, e) a Road map of the RVA (frontal view) shows
(d) the microwire (white arrow) crossing the occluded section of
the BA and (e) the distal tip of the microcatheter (white arrow)
advanced by the microwire through the thrombi; (f) a DSA of the
BA (frontal view) shows the contrast medium being injected
through the microcatheter distal to the thrombi in the BA (white
arrow); (g) the distal (white arrow) and proximal (white arrow-
head) radiopaque marks of the stent (ev3, Irvine, CA, USA) reveal
its full deployment into the distal RVA and BA; (h, i) A final control
DSA of the RVA (arterial phase, [h] frontal and [i] lateral views)
shows the complete recanalization of the BA.
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Comparing the outcomes of the present study with the
results of six large trials assessing intra-arterial treatment for
stroke, (28,30-34) our study obtained a higher recanalization
rate than the PROACT-II, MERCI, IMSII and Multi-MERCI
trials. However, our recanalization results were similar to
those of the Penumbra pivotal stroke trial and the primary
results of the SWIFT trial. The outcome (mRS scores#2 at 3
months) and three-month mortality rate results in our study
were significantly improved over the results found in the
MERCI, Multi-MERCI, and Penumbra pivotal stroke trials.
No differences were observed in the symptomatic intracra-
nial hemorrhage. The outcomes of the different trials are
presented in Table 3.
DISCUSSION
A high recanalization rate (90.4%) without an accompa-
nying increase in the number hemorrhagic complications
was observed in this prospective series of patients with
acute stroke caused by a proximal artery occlusion and
treated with intra-arterial thrombectomy with the Solitaire
AB stent (ev3, Irvine, CA, USA). In addition, a significant
proportion of patients exhibited a slight or no long-term
disability. Our overall results in the Brazilian population are
in accordance with previous studies using retrievable stents
(11-27).
The new retrievable intracranial stents have shown
superior results in large vessel occlusions when compared
with other recanalization devices and techniques. The
higher retrievable stent recanalization rates observed in
the context of acute ischemic stroke could be attributed to a
device design that is technically simpler, promotes rapid
recanalization, removes the clot, and avoids the deployment
of a definitive stent, which may lead to rethrombosis and
necessitate using a dual antiplatelet regime (11-27).
Although the preliminary trials assessing retrievable stents
have shown promising technical and clinical results, more
data regarding the use of retrievable stents in acute ischemic
stroke will be available in the near future. The results of four
large studies assessing the Solitaire device (ev3, Irvine, CA,
USA) are expected soon: the STAR Trial (Solitaire FR
Thrombectomy for Acute Revascularization - NCT01327989),
Table 2 - The main studies assessing the use of retrieval devices for treating acute ischemic stroke (searched in PubMed
through May 1, 2012).
Author - Year Sample
Mean NIHSS
baseline
Symptomatic
intracranial
hemorrhage n
(%)
3 month
mRS#2 n (%)
90-day
mortality n
(%)
Mean time from
onset to
recanalization
(minutes)
Mean
procedure
time (minutes)
Mean
number of
device passes
TICI 2b, 3
n(%)
Castanho et al. 2010 20 19 2 (10) 9 (45) 4 (20) 422 50.0 1.4 18 (90)
Roth et al. 2010 22 19.4 2 (9) 11 (50) 4 (18.1) 277 NR 1.7 20 (90.9)
Naiak et al. 2010 7 18.8 1 (14.2) 4 (57) NR 244 84.0 1.8 4 (57)
Brenkfeld et al. 2011 17 19 0 (0) 7 (43) NR NR 52.5 1.3 16 (94.1)
Costalat et al. 2011 50 14.7 5 (10) 27 (54) 6 (12) 377 54.0 2.0 44 (88)
Mendes Pereira et al.
2011
141 18 NR 77 (54.6) 29 (20.5) NR 45 NR 121 (86)
Rohde et al. 2011 10 19 2 (20) NR 3 (30) 260.7 88.7 3.0 10 (100)
Fesl et al. 2011 14 16.5 4 (29) 6 (45) 1 (8.3) 267.0 29.0 NR 13 (93)
Miteff et al. 2011 26 21.4 NR 11 (42.3) 5 (19.2) 476.4 95.6 NR 11 (42)
Mohlenbruch et al.
2011
25 14 3 (12) 15 (60) 2 (8) 237 54 2.0 22 (88)
Park et al. 2011 8 18.3 0 (0) 4 (50) 0 (0) 221.7 41.5 1.5 8 (100)
Stampfl et al. 2011 18 21 3 (16.6) 6 (33.3) 5 (27.7) 289.2 48.3 NR 16 (88.8)
Cohen et al. 2012 17 20.5 2 (11.7) 15 (88.2) 1 (5.8) 299.1 45 2.3 16 (94.1)
Mpotsaris et al. 2012 26 16 NR 10 (38.4) 2 (7.6) 327 NR 2.1 18 (69.2)
Parrilla et al. 2012 48 17.4 NR NR NR 409.3 121.3 NR 48 (100)
San Roma´n et al.
2012
60 18 7 (12) 27 (45) 17 (28) 302 80 NR 44 (73.3)
Menom et al. 2012 14 13.6 1 (7.1) 8 (57.1) 2 (14.2) NR 84 NR 12 (85.7)
Total 523 17.9 38 (13.4) 465 (50.1) 81 (17.9) 316.3 64.8 1.9 441 (84.3)
Castro-Afonso et al.
2012
21 17 3 (14.2) 13 (61.9) 2 (9.5) 356.5 60.1 3.1 19 (90.4)
Table 3 - The outcomes of the present study compared to the results from 6 large trials assessing intra-arterial treatment
for acute ischemic stroke.
PROACT-II MERCI IMSII Multi-MERCI
Penumbra pivotal
stroke trial
SWIFT trial
(SolitaireTM arm) Present study
Sample (*), n 121 141 55 164 125 58 21
Recanalization, n (%) 80 (66.1)
p=0.037
68 (48.2)
p,0.001
33 (60.0)
p=0.013
112 (68.2)
p=0.041
102 (81.6)
p=0.530
48 (88.9)
p=0.499
19 (90.4)
Symptomatic intracranial
hemorrhage, n (%)
11 (9.0)
p=0.436
11 (7.8)
p=0.396
8 (14.5)
p=0.999
16 (9.7)
p=0.458
14 (11.2)
p=0.713
1 (1.7)
p=0.055
3 (14.2)
3-month mortality, n (%) 30 (24.7)
p=0.161
61 (43.2)
p=0.003
13 (23.6)
p=0.212
56 (34.1)
p=0.024
41 (32.8)
p=0.037
10 (17.2)
p=0.499
2 (9.5)
3-month mRS#2, n (%) 48 (39.6)
p=0.093
39 (27.6)
p=0.005
37 (67.2)
p=0.788
59 (35.9)
p=0.031
52 (41.6)
p=0.010
32 (58.2)
p=0.619
13 (61.9)
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the IMSIII Trial (Interventional Management of Stroke III -
NCT00359424), the EXTEND-IA (Extending the Time for
Thrombolysis in Emergency Neurological Deficits -
NCT00887328), and the THRACE trial (Trial and Cost
Effectiveness Evaluation of Intra-arterial Thrombectomy in
Acute Ischemic Stroke - NCT01062698).
The main limitations of the present study are the lack of
a control group and the small sample size. Therefore,
our conclusions concerning the safety and efficacy of the
procedure are limited. The one-year study duration also
precluded an analysis of the local learning curve.
Nevertheless, the initial reports regarding the safety and
effectiveness of new devices and technologies are usually
the first critical step in the rapidly evolving field of
endovascular intervention.
Despite the small sample size, the use of the Solitaire AB
device (ev3, Irvine, CA, USA) in a Brazilian population
provided good technical and clinical results. Our results
underscore the importance of a combined stroke team and
the enrollment of patients under a strict stroke protocol.
Considering the recent efforts to organize an acute stroke
network in Brazil (5), we believe that this study could serve
as a preliminary ischemic stroke treatment model and thus
motivate the government, hospitals and public health
administrators to widely support and promote acute stroke
care for the Brazilian people.
Intra-arterial thrombectomy with the Solitaire AB device
(ev3, Irvine, CA, USA) appears to be safe and effective and
provided a high recanalization rate when used with a strict
stroke protocol. Large randomized trials are necessary to
confirm the benefits of this treatment approach to acute
ischemic stroke.
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